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Friend or Foe? Can We Selectively Shut Off Immune Responses?
Abstract
In lieu of an abstract, below is the first paragraph of the paper.
The immune system of the human body serves as both an enemy and an ally. It is an ally when it
constantly fights off attacks from several types of microbes. However, it is an enemy when it attacks a
life-saving heart transplant or mistakenly eats away the tissues of the body (Marx, 1990). It is the job of
the immune system to keep the body healthy and free of harmful substances. Researchers have been
aiming for ways to suppress certain parts of the immune system while not interfering with the entire
defenses of the body. By analyzing how the immune system works researchers can gain a better
understanding on what might help them succeed in this process (Janeway & Travers, 2006).
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Friend or Foe: Can We Selectively Shut Off
Immune Responses?
Kristin McCoy
The immune system of the human body
serves as both an enemy and an ally. It is an ally
when it constantly fights off attacks from several
types of microbes. However, it is an enemy when it
attacks a life-saving heart transplant or mistakenly
eats away the tissues of the body (Marx, 1990). It is
the job of the immune system to keep the body
healthy and free of harmful substances. Researchers
have been aiming for ways to suppress certain parts
of the immune system while not interfering with the
entire defenses of the body. By analyzing how the
immune system works researchers can gain a better
understanding on what might help them succeed in
this process (Janeway & Travers, 2006).
The immune system serves a very
significant role in the human body. The body is
persistently invaded with substances that can cause
harm such as toxins, fungi, bacteria, parasites and
viruses. If any of these microbes entered the body
and were left untouched the body would become
damaged. It is the role of the immune system to act
as an army and to defend against the constant
stream of foreign invaders. The immune system is
the key element in retaining the overall health of the
body and resistance to disease (Janeway & Travers,
2006).
The immune system is organized into innate
and adaptive components. The innate system serves
as the first line of defense. The innate system uses
nonspecific cells such as phagocytic cells to interact
with the microbe and protect the host. Natural killer
cells are important in the innate response because
they can lyse virally infected cells. Interferons also
work in the innate response by inhibiting the
replication of viruses (Nairn & Helbert, 2007). If the
invading microbes become too numerous and the
innate system is overwhelmed, the adaptive system
is triggered. This system has the capability to
distinguish self from nonself. However, the adaptive
system does not happen as rapidly as the innate
system does. The adaptive system takes many days
to mobilize.
The fact that each lymphocyte
expresses a unique antigen receptor is critical to
understanding the adaptive system. When an
antigen comes in contact with a lymphocyte
containing the receptor that fits with the particular
antigen, the pre-existing cells divide and produce
genetically identical daughter cells. This results in an
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increased availability of receptors specific for a
particular antigen (Nairn & Helbert, 2007). The
adaptive immune system is categorized by three
major features. The first feature is specificity. The
immune system is described as specific because it
discriminates among a variety of molecular entities.
The adaptive system is diverse because it has the
ability to respond to various antigens that it
encounters.
Lastly, the adaptive system is
characterized by having a memory. The adaptive
system can remember previous antigens that
infected a particular area and therefore increase the
strength of response when infected again. This
mechanism is referred to as immunological memory.
Immunological memory adds to the overall strength
of immunity of the body (Kamradt & Mitchision,
2001).
The state of having adequate biological
responses to microbes is known as immunity
(Kamradt & Mitchinson, 2001). Immunity has three
further divisions known as active/adaptive
immunity, innate and passive immunity.
The
individual plays a direct role in response to an
antigen in active immunity. This type of immunity
develops as children and adults experience different
types of invaders throughout their lifetime. Also,
active immunity is protective immunity that results
after exposure to an infection or a vaccination.
Lymphocytes play a major role in active immunity
(Kamradt & Mitchinson, 2001). Lymphocytes are
cells that are involved in the recognizing of previous
invaders and destroying them. These cells originate
in bone marrow and either remain there or further
mature into B cells. They can also migrate to the
thymus gland and mature into T cells.
B
lymphocytes serve as the military intelligence
system. B cells watch for the targets and then
construct a plan to capture their targets. T cells are
the soldiers, using the intelligence system that the B
cells have previously created to destroy the invader.
In general, the structure of lymphocytes remains
similar throughout the different types. Lymphocytes
are usually small, and most of the DNA and protein is
located inside the nucleus. Receptors are located on
the surface of lymphocytes. Each receptor is specific
for a particular antigen. Lymphocytes travel through
the bloodstream and peripheral lymphoid organs.
The three main types of peripheral lymphoid organs
are the spleen, lymph nodes, and the gut-associated
lymphoid tissue. The spleen serves the role of
collection of the antigens from the bloodstream.
The lymph nodes collect antigens from the tissues at
cites of infection and the gut-associated lymphoid
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reaches a cell containing the particular receptor the
cell becomes activated and proliferation occurs. As
more clones of the same cells are produced the next
phase, activation, is triggered. During this phase the
cells differentiate and enable a response. In turn, the
antibodies try to eliminate the antigen in the
effector phase. Once the antigen is fully eliminated
a series of steps occur to regulate the response and
more importantly inhibit the response from
occurring once the antigen is neutralized (Nairn &
Helbert, 2007). An active immune response is an
involuntary action but does there lie a way to make
an immune response voluntary?

tissue collects the antigens from the gut. These
components of the immune system are essential to
proper functioning (Janeway & Travers, 1996).
The second type of immunity, passive
immunity, involves the transferring of responses
from one individual to another. The immune cells
from an immunized individual get passed to an
unimmunized individual. The anti-rabies shot is an
example of passive immunity. After a dog bite, the
victim is treated with anti-bodies to the rabies virus;
however they have been produced by individuals
other than the victim. Another example of passive
immunity is the antibodies in the breast milk of
mothers, which provide temporary protection for
the infant. The final type of immunity, innate
immunity, includes the external barriers of the body.
The external barriers of the body are technically the
first line of defense in preventing disease (Nairn &
Helbert, 2007). The degree of immunity regulates
the types of immune responses needed to keep the
body healthy.

The regulation of immune responses is the
major medical goal of research in the field of
immunology.
Researchers want to be able
manipulate immune responses in way that would
enable suppressing the response when it is
unwanted and stimulating a response in such cases
of prevention of infectious disease. Suppression of
the immune system includes the topic of organ
transplant. If there was a way to induce the immune
system to tolerate a transplant the patient would no
longer have to take immunosuppressants for the
rest of his/her life. The implications of discovering a
way to suppress the immune system could help with
treatment of autoimmune diseases. The reason why
this has not yet been discovered is because the
immune system is very particular and sensitive.
Manipulating with one part of the response can
cause the whole immune system to react. Also
specifically with organ transplants, there is no way to
judge if tolerance has occurred unless the patient is
taken off of the immunosuppressant drugs which
provides an increased risk of rejection.
Immunologists have discovered many techniques for
inducing, measuring, and characterizing immune
responses. (Janeway & Travers, 1996). Allergic
reactions and organ rejections are two major areas
of research dealing with suppression of the immune
system.

The immune system is the driver behind
immune responses.
Immune responses are
integrated bodily reactions to antigens. The immune
system uses a series of steps to trigger immune
responses which will attack the organisms and
substances that invade the human body and aim to
cause disease. Immune responses are the way in
which the body recognizes and defends itself against
the bacteria, viruses, and other material that may
appear harmful to the body (Nairn & Helbert, 2007).
Foreign substances that invade the body
are known as antigens. When the body detects that
an antigen has entered, many cells work together in
the recognition of the antigen and a response to
defeat the antigen. These cells immediately trigger
the B cells which start to produce antibodies.
Antibodies are specialized proteins that lock onto
specific antigen receptors. These antibodies remain
in the body even after the invader is destroyed. This
is an advantage because if the invader returns into
the body, the antibodies will already be present and
immediately destroy the foreign substance.
Antibodies can not work single-handedly on this
task. Once they have bound to the receptor on the
antigen the T cells destroy the antigen that has been
tagged with antibodies (Marx, 1990). These antigens
are the substances that trigger an active immune
response.

In the case of organ failure, transplantation
has become the most common and efficient
procedure to replace the organ. The main risk of
organ transplantation is the rejection of the allograft
by the host of the immune system. To avoid
rejection of the transplant a variety of
immunosuppressant drugs are used to target the
adaptive T -cell response. Many of these same drugs
are used to treat allergic reactions. It is therefore
predicted that those patients using the
immunosuppressant drugs should at no point while
under therapy develop an allergic reaction to any

An active immune response involves a
series of steps initiated by the immune system. The
first phase is the cognitive phase in which the
particular antigen is recognized. When the antigen
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sensitization followed by the lung recipients. The
same order from greatest to least, kidney, liver, lung
was displayed for the negative skin prick results. The
data display the prevalence of allergy in the patients.
89.7% of all patients had no allergy, defined in this
study as a sensitization and additional history of
allergic disease. 10.3% were defined as having the
prevalence of allergies (Dehlink, 2006).

substance. The objective of this study was to
evaluate in a cross-sectional design, the prevalence
of immunoglobulin E-mediated sensitizations and
type 1 allergy in solid-organ transplanted children
and adolescents and to identify the risk factors
(Dehlink, 2006).
The participants came from the Medical
University of Vienna between the years of 2004 and
2005. In total there were seventy eight patients with
kidney, lung or liver transplants used. The patients
were treated with different combinations of
steroids, proliferation inhibitors, kinases and
phospatases inhibitors based on the individual
patient. The medical charts of the patients were
marked with the date of transplantation as well as
the starting date of immunosuppressive therapy. To
determine if there was a history of allergies in the
patient or in the family, the patient was given an
interview based on the International Study of
Asthma and Allergies in Childhood criteria. The
allergic sensitizations of each patient were examined
by serum-lgE measurements and a skin prick test.
The serum -IgE measurements were conducted by
using a solid-phase immunoassay. The patients were
tested for dust mite, cat and dog dander, cod fish,
wheat flour, soy bean, peanuts, hazelnut, almond,
coconut, rye, birch and other common allergens.
Other sensitizations were tested if there was some
other allergen present in the family determined in
the survey. The total serum-lgE levels were
converted into z units to account for the various
differences in ages. The skin prick test was used to
test a panel of allergens. To avoid interference with
the skin prick test the patients were advised to stop
using antihistamines for two weeks prior to the test.
If there was further indication of specific allergens in
the patient's history those were also done in the skin
prick test. Each patient was classified as sensitized
if they presented a positive skin prick test and had a
reaction to at least one of the allergens or as allergic
if they had additionally history of allergic diseases in
the family (Dehlink, 2006).

The results of this study were surprising.
The population of patients consisted of 50 kidney
transplant patients, 19 liver transplant patients, and
9 lung transplant patients. All of the patients did
take part in the interview and serum IgEmeasurements. However, there were 20 allograft
recipients that refused to take a skin prick test. Out
of the total population of 78 patients, 19 were
discovered to be sensitized to allergens and 16
patients of those 19 patients displayed particular
serum IgE. Also 13 of the 19 had a positive skin prick
test to at least 1 allergen. Only 8 participants of the
total population were designated as "allergic"
because they reported a clinical history to type 1
atopic diseases. The prevalence of sensitization and
allergy was similar among all three types of
transplant patients although between the subgroups
the spectrum of sensitizations was different. Both
kidney and liver recipients were sensitive to nutritive
and inhalant allergies while the lung recipients were
solely sensitive to inhalant allergies. The sensitized
patients did not differ too much of an extent from
the nonsensitized patients in regards to gender, age,
date of transplant, history of allergies, or time of
immunosuppressive medicine. No major differences
were found when analyzing the various types of
immunosuppressants or duration of the treatment
(Dehlink, 2006).
These results show that regardless of the
immunosuppressive treatment, the organ transplant
patients still can acquire certain sensitizations to
inhalant or food allergies. The immunosuppressive
treatment does not prevent allergic reactions. The
most common symptoms of the allergies were
seasonal rhinitis and rhinoconjuctivitis.
No
immunosuppressive drug was proven to be
associated with the occurrence of allergies. There
was no correlation between the transplanted organ
and the prevalence of allergy because sensitization
and allergy were equally distributed.
It was
demonstrated
that
the
long-term
immunosuppressive therapy does not have an effect
on allergies in transplant patients. One suggestion
for these results could be that the allergy had
already existed before the organ allograft took place.

The data depict the prevalence of
sensitization as well as the allergies among the
patients. The sensitization refers to a positive result
from the skin prick test or a specific IgE level greater
than 0.35. 75.6% of the total number of patients had
a negative result to the skin prick test while 24.4%
had a positive sensitization. The majority of the
positive skin prick results came from the kidney
patients, but what also must be taken into account is
that the greatest numbers of patients were kidney
recipients. The next highest percentage were of
11
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CD4 is a marker of the helper T cell subset that
interacts with
B lymphocytes in induce
immunoglobulin production or activate other
immune cells via cytokines (Ling, 2004). Cytokines
are small proteins produced by T cells that act as
signals to other cells of the immune system or
structural cells. CD25 is the chain of the receptor for
interleukin 2. T cells are cells that control immune
responses by recognition of specific sequences from
foreign molecules presented by MHCs on antigen
presenting cells. The correlation between activity of
regulatory T cells and disease in humans was
investigated. Analysis of the mechanism involved in
suppression of allergen- induced T cells was also
conducted (Ling, 2004).

In this case the immunosuppressive drugs would not
be able to control the allergen. The allergy may also
develop within the time period of therapy and the
immunosuppressive drugs do not recognize it as a
foreign substance. In many cases of developing an
allergy during post transplantation drug treatment
the calcineurin inhibitor tacrolimus seemed to be the
cause. This suggests that the immunologic
mechanism behind this could be a suppression of the
T-helper cells (Dehlink,2006). The presence of the
allergen before the therapy was started is a
possibility but there must be a underlying cause.
Perhaps the allergen was present but not active
inside the body, the immunosuppressant drugs
triggered the allergen and therefore the symptoms
of an allergic reaction appeared. An allergic reaction
is a response from the immune system.

The participants in this study were
volunteers. Patients with seasonal allergies to grass
pollen were from an allergy clinic. Atopic donors
had positive IgE skin test and a history of allergic
symptoms. The non-atopic donors had negative skin
prick tests and no history of allergic symptoms in the
past. The seasonal allergy donors had positive skins
test to grass pollen but to no other allergens. The
first part of the procedure involved cell separation.
Blood samples were obtained and basic cell culture
with the allergen extract was performed. The PBMC
of the allergen was separated using density
centrifugation. The CD4 + T cells were isolated by
negative selection and the CD5 + T cells were
isolated using positive selection. The CD4 + cells
were enriched to a median of 96% while the CD25 +
cells were enriched to a median of 82%. The cells
were cultured in well plates with allergen extracts.
Autologous irradiated mononuclear cells were added
as antigen presenting cells to all cultures. The
cultures contained the following: PBMC's, CD4 +
CD25+ cells alone, CD4+ CD25- cells alone, CD4+
CD25- and CD4+ CD25+ T cells at a ratio of two to
one to control for the amplified cell density of the
CD25 + CD25- cultures. Supernatant was added for
cytokine analysis with the Luminex bead system. Hthymidine was also added to the culture. After the
cells were harvested, counting of incorporated
radioactivity as index of proliferation occurred.
(Ling, 2004).

The immune system releases a response to
antigens that trigger certain allergic reactions. An
allergy or atopy is an immediate hypersensitivity to
reaction to environmental antigens, mediated by
immunoglobin E (IgE). Allergies are very rapid
reactions and the symptoms of a reaction occur
within minutes of exposure to the particular antigen.
The specific antigens that trigger the allergic
reactions are called allergens. Allergens find a way
into the body either by inhalation, becoming
ingested, or injecting directly into the skin.
Treatment of allergies is simply identification of the
particular allergen that is causing the allergy and
avoidance of those harmful allergens (Nairin &
Helbert, 2007).
Mast cells and eosinophils are the cells
involved in allergies. Mast cells are resident in a
wide number of tissues, whereas eosinophils
migrate into tissues where type I hypersensitivity is
taking place (Nairin & Helbert, 2007). These
eosinophils release the mediators that cause the
reaction to the allergen. After the specific allergen
and IgE have come in contact with each other the
mast cells initiate the symptoms of an allergic
reaction. The production of IgE is essential for
hypersensitivity reactions. Once the B cells are
stimulated by interleukin-4 and T-helper 2 cells, the
production of IgE begins. IgE then binds to FccRI
which is located on the mast cells in tissue and
eosinophils that have been activated. This is why
when investigating the cause of the allergic reaction
the IgE levels can be tested and used to help find the
answer (Ling, 2004).

CD4+ CD25, CD4+ CD25- T cells, or mixed
CD4+ CD25 + and CD4 + CD25- cells in a were
cultured in order to compare the regulation of nonallergen driven cultures between atopic and nonatopic donors. A cat allergen reactive Th-2 clone
was generated from an atopic donor by using
limiting dilution. This clone produced interleukin 5
and interleukin 13. A cat allergen peptide reactive

To determine whether the amount of
inhibition of allergic responses by CD4 + CD25 + T
cells was related to allergic disease CD4 was used.
12
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ThO clone was generated from a non-atopic donor.
This clone produced interleukin 2, interleukin 5, and
interleukin 13. The clones were combined in a
mixing experiment with CD4+ CD25+ Tcells. The cells
were cultured. Blocking antibodies were added.
Flow cytometry was conducted on CD4+CD25 - T
cells. RNA was extracted from CD4+ CD25 + and
CD4+ CD25- cell pellets with a kit. RNA was
quantified
and
then
underwent
reverse
transcription. PCR procedures in triplicate sequence
detection system were performed. (Ling, 2004).

course greater when the individuals were studied
out of season. No difference was discovered in the
proportion of CD4+ cells positive for CD25+ between
groups or in expression of CD69 or intracellular CTLA
4 on regulatory T cells than the activated T cells. To
test capability of suppression of the T cells, allergen
specific T cell clones were obtained. It was displayed
that CD4+CD25 T cells suppressed proliferation of
the Th2 clone from the atopic donor. The CD4+CD25
T cells inhibited proliferation of a peptide-specific
ThO clone from the same nonatopic donor. The
antibody to glucocorticoid-induced tumor necrosis
factor receptor reversed cell suppression but the
antibodies against this receptor did not reverse
inhibition of interleukin 5, 13, or y production (Ling,
2004).

The data represent the mechanisms of
suppression. The data display the proliferation of a
Th2 cell clone by CD4+CD25+ T cells from an atopic
donor. The proliferation is recorded in units of cpm
for three separate experiments. The first, CD4+25+,
shows a proliferation value of 0 cpm. The second
experiment shows the T cell clone which had a
proliferation value of approximately 67,000cpm.
The third experiment is the T cell clone with CD4+ 25
+. The proliferation value for this experiment was
approximately 10,000cpm. The data show the
allergen-induced T cell proliferation and cytokine
production by CD4+CD25+ T cells with and without
the presence of the antibody to glucocortitoidinduced tumor necrosis factor receptor. The data
reveal the information from one donor which
represents three different experiments. This data
came from a non-atopic donor. The data display the
control antibody and the antibody glucocortitoidinduced tumor necrosis factor receptor for CD4+25+,
CD4+25-, and CD4+25-CD4+25+. The proliferation in
order from least to greatest is as follows: CD4+25+
CD4+25-CD4+25+ and CD4+25. (Ling, 2004).

The suppression of CD4+ CD25 + T cells
relates to the existence of clinical allergies has been
demonstrated. This is due to the fact that the
inhibition of the allergen-driven responses by cells
from atopic donors was less than the non-atopic
donors and the least by those cells isolated from the
patients with seasonal allergies. Both the atopic-and
nonatopic donors showed growth of PBMC's to
allergens in the culture. However, they showed
differing results in the production of Th2 cytokines.
This study demonstrated that T cells can suppress
allergen-driven proliferation as well as cytokine
production (Ling, 2004).
The major result of this study is that as T
ceil activation is reduced in atopic versus nonatopic
individuals and reduced even greater when exposure
to an allergen is observed suggests many
possibilities. The data suggest that there may be a
deficiency in the regulation of CD25+ T cells in the
atopic donors. Another possibility is the dilution of
regulatory CD25+ T cells during allergen exposure.
Another suggestion is that when exposed to an
allergen the effector T cells are activated in a way
that they do not respond to signals from the CD4+
CD25+ T cells. Those patients with hay fever had a
reduced ability of the T cells to suppress allergen
responses. This suggests that perhaps their CD25cells had been activated by certain mechanisms and
therefore was not responsive to regulation. The
data collected in this study suggests several reasons
why some children develop allergies while others do
not. The first reason could be an absence of Thl
responses which deal with infection. A deficiency in
the maturation of the T cells could exist and this
would therefore lead to unchecked Th2 responses.
In atopic sensitization, there is a defect in the
regulation of Th2 responses to T cells. The study

The CD4+ CD25 + T cells from non-atopic
donors showed little or no proliferation at all when
stimulated by allergens. The culture of CD4+ CD25T cells with allergen showed a substantial amount of
proliferation as well as production of interleukin 5.
The non-atopic individuals with asymptomatic and
symptomatic atopic allergic patients were
compared. The percentage suppression of allergen
driven proliferation of CD25- T cells by CD25+ T cells
was substantially reduced when the cells of the
atopic donor was compared with cells from the nonatopic patients. The suppression of interleukin 5 by
CD4+ CD 25 + T cells in cultures of asymptomatic
donors did not differ significantly from the nonatopic volunteers. In the patients with seasonal
allergies CD4+CD25+ Tcell inhibition of grass pollen
and allergen stimulated proliferation and production
of interleukin 5 was lower than the non- atopic and
atopic patients. Suppression of proliferation was of
13
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has already occurred. The race was started more
than 60 years ago and the finish line is in sight.

suggests that CD4+ CD25 + T cells can prevent the
activation of certain Th2 responses in non-atopic
donors. Failure of such suppression could result in
allergic disease. This implies that certain T-cell
mediated diseases are results of an imbalance
between inhibition and activation of T cells (Ling,
2004).
The data suggest that by dissecting a
particular pathway of the immune system the
possibility of therapy on the pathway exists.
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The future in immunology looks impressvie,
specific suppression of immune responses is in sight.
Scientists have recently discovered how to grow cells
that suppress immune responses. Scientists have
found a way to grow T- regulatory cells type 1.
These cells are predicted to be the key to turning off
unwanted immune reactions. These cells could even
inhibit the action of certain immune cells that if not
blocked would attack the body. This discovery could
help with the developments of new treatments and
therapies for many autoimmune diseases. It could
also provide scientists with a better understanding
of infectious diseases and could help in organ
rejection after transplantation. Using this technique,
scientists can now take a blood sample from a
patients arm ad culture the cells. A few days later
the cultured cells will be t-regulatory cells. The hope
of researchers is to continue studying the factors
involved in the differentiation and function of the T
regulatory cells type 1. Once these factors are
identified manipulating the activity of the Trl cells
for therapeutic use will be possible.
Other
colleagues found that the stimulation of CD46 and
the T-cell receptors caused the growth of t
lymphocytes which produced interleukin 10. This is
also groundbreaking because interleukin 10 is the
substance that suppresses the action and
proliferation of immune cells (Kemper, 2003).
The immune system is essential to the
overall health of the body. If it was manipulated in a
certain way to suppress unwanted responses but at
the same time not lower the degree at which it
protects the body, some diseases would no longer
be existent. Allergies to a common environmental
substance, rejection of a life saving organ, and
maternal antibody that causes the fetus to become
affected by erythroblastosis would all be gone
(Rowley, 1973). The possibilities if suppression was
discovered would be endless. In the future it may be
beneficial to suppress the antibody response to a
tumor. Perhaps an antibody to the tumor prevented
immunologic injury to the tumor.
Small
manipulations and inhibition of immune responses

14
https://fisherpub.sjf.edu/ur/vol12/iss1/5

6

